Drug profile

The FDA adverse-event record for Unspecified Ketamine

The CVM extract lists 10 reports for Unspecified Ketamine, a lower-volume entry. Species, reactions, and outcomes are below.

#2670 of 2,679
by report volume (all drugs)
10
adverse-event reports
0.0%
death-coded share
Dog
most-reported species
Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Unspecified Ketamine ranks #2536 of 2679 by total reports (10). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#2536
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Signature read: 10 reports place Unspecified Ketamine in the lower third of FDA AER volume (#2670 of 2,679).

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
0
Deaths Reported
0.0%
Death-coded share of reports

Active Ingredients

Unspecified Ketamine

Administration Routes

UnknownSubcutaneous

Species Affected

Dog 6
Cat 4

Most Affected Breeds

Retriever - Labrador 3
Cat (other) 2
Domestic Shorthair 1
Cat (unknown) 1
Shepherd Dog - German 1
Retriever - Golden 1
Dog (unknown) 1

Most Reported Reactions

Abnormal radiograph finding 4
Fever 3
Bone and joint disorder NOS 3
Joint pain 3
Abnormal histology NOS 3
Arthropathy NOS 3
Limb non-weight bearing 3
Joint swelling 3
Lack of efficacy - NOS 3
Seizure NOS 1
Anaemia NOS 1
Eosinophilia 1

Outcome Breakdown

Recovered/Normal
4 (40.0%)
Ongoing
4 (40.0%)
Outcome Unknown
2 (20.0%)

Unspecified Ketamine: low death-coded share in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Next steps with this data

  • Before drawing conclusions from this number, read why death-coded share is not the same thing as a mortality rate. Understanding adverse events
  • The full drug directory has report counts for every product we track. All drugs

Correlation in adverse-event counts is not causation; consult a veterinarian before making a decision from this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Unspecified Ketamine (#2670 of 2,679 by report volume); death-coded 0.0%. PlainBreed drug row · report volume stamp 10 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →